We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Technique Restores Fertility to Patients with Fibroids

By HospiMedica International staff writers
Posted on 19 Jun 2017
Researchers have shown that Uterine Fibroid Embolization (UFE) treatments can enable women suffering from uterine fibroids to become pregnant again.

Uterine fibroids often cause infertility and complications during pregnancy, and current standard treatments consist of surgery to remove the fibroids that may cause complications such as hysterectomy, and is not always effective. More...
UFE treatments on the other hand are not yet fully accepted for fertility-preserving treatment in women with symptomatic fibroids.

The researchers from the Department of Interventional Radiology at the Saint Louis Hospital (Lisbon, Portugal) registered the pregnancy rates of 359 women with fertility problems who suffered from uterine fibroids, for a period of nearly six years. All of the women had undergone either partial or conventional UFE treatment. The study was published online in the June 2017 issue of the journal Radiology.

The results of the research showed that 149 women (41.5%) in the study group became pregnant at least once during the 6-year study period. The clinicians used Magnetic Resonance Imaging (MRI) scans and digital subtraction angiography imaging to visualize partial UFE.

Study co-author João Martins Pisco, MD, PhD, from the Department of Interventional Radiology at Saint Louis Hospital in Lisbon, Portugal, said, “Our findings show that UFE is a fertility-restoring procedure in women with uterine fibroids who wish to conceive, and pregnancy following UFE appears to be safe with low morbidity. Women who had been unable to conceive had normal pregnancies after UFE and similar complication rates as the general population in spite of being in a high-risk group. In our study there are now almost 200 newborns following UFE. Our next step will be a randomized study comparing the results of partial and conventional UFE."

Related Links:
Saint Louis Hospital


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
External Defibrillator
HeartSave Y | YA
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.